JM sisco pharma BPN consultant

Ended Purchase Order Awarded Last action

Contract number
75N95019P00670
Awardee
Awarding agency
Obligated
$113,958

Award facts

Opportunity
Contract value 24% obligated
  • $113,958.00 Current, with exercised options
  • $467,958.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
Pricing
Labor Hours
Place of performance
Bethesda, MD 20892, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00008 -$38,990
Funding Only Action P00007 · To administratively DE-obligate unexpended and expiring fiscal year 2020 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30,… -$4,052
Funding Only Action P00006 $15,000
Exercise an Option P00005 · JM sisco BPN consultant - ninds BPN chemistry manufacturing control (CMC)/pharmaceutics/formulation consultant support services $50,000
Exercise an Option P00004 · JM sisco BPN consultant add 80 additional hours during base period: 9/20/2019-9/19/2020 $16,000
Exercise an Option P00003 · JM sisco BPN consultant add 30 additional hours during base period: 9/20/2019-9/19/2020 $6,000
Exercise an Option P00002 · JM sisco BPN consultant add hours during base period: 9/20/2019-9/19/2020 $20,000
Exercise an Option P00001 $20,000
Original award $30,000

About this award

The National Institute on Drug Abuse issued a purchase order to JM Sisco Pharma Consulting, LLC, a small business, on September 16, 2019, with a ceiling value of $467,958.00 to administratively de-obligate unexpended and expiring fiscal year 2020 funding in accordance with 31 U.S.C. Section 1552(a). The order is set aside for Total Small Business. Work is performed in Bethesda, Maryland. The order was issued under a labor-hour pricing structure with an ultimate completion date of September 19, 2022. Actual government-invoiced labor declined across fiscal years: FY2021 recorded $41 thousand across 203 contractor hours (0.1 FTEs) at $200.01 per hour; FY2022 recorded $9 thousand across 44 contractor hours (0.0 FTEs) at $200.00 per hour. The awardee self-performed all work without subcontractors.

Quick answers

Who was awarded contract 75N95019P00670?

75N95019P00670 was awarded to JM Sisco Pharma Consulting, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 16, 2019.

How much is contract 75N95019P00670 worth?

The government has obligated $113,958 on 75N95019P00670. Its potential value, with all options, is $467,958.

Was contract 75N95019P00670 competed?

The extent of competition for 75N95019P00670 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award